Related Experiment Videos

Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants

P G Davis1, D J Henderson-Smart

  • 1Division of Paediatrics, Royal Women's Hospital, 132 Grattan St, Melbourne, Victoria, Australia, 3053. p.davis@obgyn-rwh.unimelb.edu.au

Insights

Nasal continuous positive airway pressure (NCPAP) effectively prevents extubation failure in preterm infants after intermittent positive pressure ventilation (IPPV). This reduces the need for additional respiratory support, improving outcomes for vulnerable newborns.

Area of Science:

  • Neonatal Medicine
  • Respiratory Physiology
  • Clinical Pediatrics

Background:

  • Preterm infants extubated after mechanical ventilation risk respiratory failure due to apnea, acidosis, and hypoxia.
  • Nasal continuous positive airway pressure (NCPAP) stabilizes the upper airway and improves lung function, potentially aiding extubation.

Purpose of the Study:

  • To evaluate if NCPAP management post-extubation increases the proportion of preterm infants free from additional ventilatory support compared to headbox oxygen.

Main Methods:

  • Systematic review of randomized or quasi-random trials comparing NCPAP with headbox oxygen for post-extubation care in preterm infants.
  • Data extraction and quality assessment by two independent authors.
  • Analysis using relative risk (RR), risk difference (RD), and number needed to treat (NNT).

Main Results:

  • NCPAP significantly reduces adverse clinical events (apnea, acidosis, increased oxygen needs) requiring additional ventilation (RR 0.62, NNT 6).
  • A non-significant trend towards reduced chronic lung disease at 28 days was observed in the NCPAP group (RR 0.86).

Conclusions:

  • NCPAP is effective in preventing extubation failure in preterm infants post-IPPV.
  • Further research is needed to define optimal gestational age, weight groups, NCPAP levels, and administration methods.
Abstract

Related Concept Videos